Facebook Pixel Code

Brooks Laboratories Share Price

NSE
BSE

BROOKS LABORATORIES

Sector : Pharmaceuticals and health care | Smallcap | BSE

Here's the live share price of Brooks Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹152.35 Closed
0.76₹ 1.15
As on Sep 11, 2025, 4:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Brooks Laboratories Price Performance

Today's LowToday's High
₹152.00₹158.75
₹152.35
52 Weeks' Low52 Weeks' High
₹97.80₹202.80
₹152.35
Open Price
₹158.00
Prev. Close
₹151.20
Volume
15,987

Over the last 5 years, the share price of Brooks Laboratories has gained 31.65% CAGR. Over the past year, the corresponding return has been 2.77%.

Brooks Laboratories’s current P/E of -1,103.99x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.

Brooks Laboratories Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Brooks Laboratories
5.32-0.6518.6145.032.775.3731.65
Sun Pharmaceutical Industries
1.72-0.19-4.84-2.78-12.8321.9726.07
Divi's Laboratories
-1.820.59-10.348.7010.7717.8913.85
Cipla
-1.053.832.577.94-4.0913.6116.56
Torrent Pharmaceuticals
-0.59-1.0611.5216.854.0333.3620.31
Dr. Reddy's Laboratories
3.936.85-3.5416.65-1.4815.188.16
Mankind Pharma
1.326.719.3317.636.8422.2212.79
Zydus Lifesciences
3.169.266.6716.01-6.1340.4823.06
Lupin
2.612.25-1.850.69-9.9143.6315.52
Abbott India
-4.03-6.37-2.291.294.7619.4612.93
Alkem Laboratories
1.6711.3610.3512.92-14.0318.9513.22
Aurobindo Pharma
7.195.40-4.351.70-26.3826.296.69
Glenmark Pharmaceuticals
6.543.5529.6351.4322.7575.8634.32
Biocon
1.936.362.6810.59-5.606.23-3.41
GlaxoSmithKline Pharmaceuticals
0.636.33-15.417.640.1126.2211.31
Laurus Labs
2.467.6532.2355.8976.7017.8528.89
Anthem Biosciences
-2.738.9412.4112.4112.413.982.37
Cohance Lifesciences
10.876.03-0.50-13.73-16.3127.9423.52
Ipca Laboratories
-2.11-2.04-5.711.51-8.7314.405.38
Gland Pharma
4.151.5116.8922.124.01-5.961.55

Over the last one year, Brooks Laboratories has gained 2.77% compared to peers like Sun Pharmaceutical Industries (-12.83%), Divi's Laboratories (10.77%), Cipla (-4.09%). From a 5 year perspective, Brooks Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (26.07%) and Divi's Laboratories (13.85%).

Brooks Laboratories Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Brooks Laboratories Stock Technicals

Moving Average

DaySMAEMA
5139.24145.76
10141.06144.88
20147.69146.04
50149.23146.3
100141.98143.58
200142.65139.41

Brooks Laboratories Share Holding Pattern

In the latest quarter, Brooks Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 10.38%, FII holding fell to 0.00%, and public shareholding moved up to 37.00% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Brooks Laboratories Corporate Actions

Date Time
Announcement
Sep 10, 2025, 5:20 PM ISTBrooks Laboratories - Intimation Of Record Date, E-Voting Dates And Book Closure Date
Sep 05, 2025, 3:18 AM ISTBrooks Laboratories - Letter To The Shareholders - Annual Report For The FY 2024-25.
Sep 05, 2025, 2:36 AM ISTBrooks Laboratories - Shareholder Meeting- AGM On 26Th September 2025.
Sep 05, 2025, 2:23 AM ISTBrooks Laboratories - Reg. 34 (1) Annual Report.
Sep 01, 2025, 5:31 AM ISTBrooks Laboratories - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

About Brooks Laboratories

Brooks Laboratories Ltd. is a Public Limited Listed company incorporated on 23/01/2002 and has its registered office in the State of Himachal Pradesh, India. Company's Corporate Identification Number(CIN) is L24232HP2002PLC000267 and registration number is 000267. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 82.56 Cr. and Equity Capital is Rs. 29.46 Cr. for the Year ended 31/03/2025.

Management

  • Ms. Sonia Gupta
    Independent Director
  • Mr. Jitendra Pratap Singh
    Whole Time Director
  • Mr. Durga Shankar Maity
    Whole Time Director
  • Mr. Bhushan Singh Rana
    Whole Time Director
  • Mr. Lalit Mahajan
    Addnl.Independent Director
  • Dr. Usha Singh
    Addnl.Independent Director

FAQs on Brooks Laboratories Share Price

What is the share price of Brooks Laboratories?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Brooks Laboratories is ₹152.35 as on Sep 11, 2025.

What kind of stock is Brooks Laboratories?

The Brooks Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Brooks Laboratories?

The market cap of Brooks Laboratories is ₹448.78 Cr as on Sep 11, 2025.

What are today's High and Low prices of Brooks Laboratories?

Today’s highest and lowest price of Brooks Laboratories are ₹158.75 and ₹152.00.

What are the 52 Week High and 52 Week Low of Brooks Laboratories?

The 52-week high/low is the highest and lowest price at which Brooks Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Brooks Laboratories is ₹202.80 and 52-week low of Brooks Laboratories is ₹97.80 as on Sep 11, 2025.

How has the Brooks Laboratories performed historically in terms of returns?

The Brooks Laboratories has shown returns of 0.76% over the past day, -0.65% for the past month, 18.61% over 3 months, 2.77% over 1 year, 5.37% across 3 years, and 31.65% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Brooks Laboratories?

P/E ratio of and PB ratio of Brooks Laboratories are -1,103.99 and 7.19 on Sep 11, 2025. While the company gives a dividend yield of 0.00 per annum.

icon
Market Data